Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02922270
Other study ID # 252
Secondary ID
Status Completed
Phase N/A
First received September 19, 2016
Last updated October 21, 2016
Start date October 1995
Est. completion date October 2015

Study information

Verified date October 2016
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Observational

Clinical Trial Summary

INTRODUCTION AND AIMS: The aims of this study were to evaluate patient and technique survival rates, investigate peritonitis rates and evaluate factors affecting mortality in peritoneal dialysis (PD) patients over a period of 20 years at Istanbul Faculty of Medicine Peritoneal Dialysis Unit.

METHODS: Two hundred seventy seven patients have received PD as renal replacement therapy (RRT) over a period of 20 years. After exclusion of patients with follow-up shorter than 3 months and patients whose data were not available, 250 patients were examined retrospectively. Data for sex, age, primary disease, comorbidities, follow up duration, cause of death, and cause of technique failure were collected from medical records.


Description:

Material and Method All patients 18 years of age and older who were treated with PD at the Istanbul Medical Faculty from October 1994 to October 2014 were included in the study. Patients exclude which follow-up shorter than 3 months and patients whose data were not available. From the day PD was started, all peritonitis data were collected prospectively in a large database. The data include Socio-demographic data, type of peritoneal dialysis, starting time and duration of every peritonitis episode, causative organisms and outcome of the peritonitis, which could be cure, change of PD catheter, transfer to hemodialysis, or death. The time in months from PD start to the first episode of peritonitis was computed.

Primary kidney disease was classified into 9 main categories according to the codes of the European Renal Association - European Dialysis and Transplant Association. Peritonitis in PD was defined as a peritoneal dialysate effluent containing >100 white blood cells/mL, of which >50% were polymorphonuclear leukocytes. Patients with two or more pathogens isolated from the cultures in a peritonitis episode were considered to have polymicrobial peritonitis. A relapse of peritonitis was defined when the same organism or a culture-negative peritonitis episode was identified within 4 weeks of completing appropriate antibiotic therapy for a previous episode.

Socio-demographic, clinical and treatment characteristics, medium (standard deviation for continuous variables) or median (25th and 75th percentages); number for categorical variables (rate) were calculated. Cox regression analysis applied to examine the impact of demographic and clinical features of periton dialysis patients . Chi-square test for categorical variables used. Univariate and multivariate analyzes calculated using the Kruskal-Wallis or Mann-Whitney test method. P-value was <0.05 for as long as it is considered statistically significant. The evaluation of the results obtained using SPSS 21.0 software.


Recruitment information / eligibility

Status Completed
Enrollment 277
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- all patients 18 years of age and older

- treated with PD at the Istanbul Medical Faculty from October 1994 to October 2014

Exclusion Criteria:

- follow-up shorter than 3 months and patients whose data were not available,

- data were not available

- patients who were unwilling

- patients who unable to provide informed consent

Study Design

Observational Model: Ecologic or Community, Time Perspective: Retrospective


Related Conditions & MeSH terms

  • Therapeutic Procedural Complication

Intervention

Other:
Peritoneal dialysis patients at the Istanbul Medical Faculty
The aims of this study were to evaluate patient and technique survival rates, investigate peritonitis rates and evaluate factors affecting mortality in peritoneal dialysis (PD) patients over a period of 20 years at Istanbul Faculty of Medicine Peritoneal Dialysis Unit.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Outcome

Type Measure Description Time frame Safety issue
Primary Patient survival 5 - 10 years Yes
Secondary Treatment failure Re-initiation of hemodialysis 5 - 10 years Yes
See also
  Status Clinical Trial Phase
Completed NCT02943928 - Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance N/A
Completed NCT04127903 - The Length of the Right Main Stem Bronchus as a Guide to Right-sided Double-lumen Tube Use N/A
Completed NCT03545737 - Compare a New Method and Formula as a Guide for the Intubation of a Left-sided Double-lumen Tube
Completed NCT02792855 - Comparing the "sniffing Position" , "Simple Head Extension" and "Neutral Position" N/A
Completed NCT02816918 - Extraluminal Use of the Bronchial Blocker of Univent Tube Phase 1
Completed NCT02669550 - Comparison of Disposcope Endoscope and Fiberoptic Bronchoscope N/A
Recruiting NCT03392818 - An Innovative Approach for Uniblocker Intubation N/A
Completed NCT03392922 - A Comparison the Intubation of a Left Sided Double Lumen Tube and Uniblocker N/A
Completed NCT03008473 - Chest CT for the Placement of the Uniblocker N/A
Not yet recruiting NCT05739318 - the Diameter of Double-lumen Tube Measured by Different Methods N/A
Completed NCT05331287 - Comparing the "Snifing Position" , "Simple Head Extension" and "Neutral Position" N/A